Saliva swabs could replace needles for virus monitoring in ovarian cancer patients
NCT ID NCT06870539
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether saliva samples can be used to remotely monitor cytomegalovirus (CMV) infection in people receiving treatment for ovarian cancer. Researchers compared saliva and blood samples from 49 participants, collected either at the clinic or at home. The goal was to see if saliva is a reliable and convenient alternative to blood draws for tracking CMV, a common virus that can cause problems in cancer patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER-RELATED COGNITIVE DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
University of Minnesota/Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can heated chemotherapy improve ovarian cancer outcomes?
- Brain fog after cancer: can a group program sharpen the mind?
- Can engineered immune cells target a common ovarian cancer protein?
- Digital therapy aims to tame the fear that haunts cancer survivors
- Experimental pill takes on Hard-to-Treat ovarian cancer
- Targeted drug hunts down cancer cells in advanced bladder cancer trial